Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

MCI · MCI-AD, Early Stage Alzheimer's Disease · Alzheimer's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Old Age Psychiatry and Psychotic Disorders Medical University of Lodz, Lodz, Łódź Voivodeship, Poland
Contact: Study coordinator (Jakub Kaźmierski)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease · Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

New York, United States

A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy

AD - Alzheimer's Disease · MCI

Abroad (travel likely)RecruitingPHASE1

Beijing, China

δ in Dementia Clinical Trials

Alzheimer's Disease (AD) · Dementia · Cognitive Decline

Abroad (travel likely)Recruiting

San Antonio, United States

The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients

MCI

Abroad (travel likely)Recruiting

Banī Suwayf, Egypt